NDC 0078-0502 Exelon
Rivastigmine Patch, Extended Release Transdermal - View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 0078 - Novartis Pharmaceuticals Corporation
- 0078-0502 - Exelon
Product Packages
NDC Code 0078-0502-15
Package Description: 30 PATCH in 1 CARTON / 24 h in 1 PATCH (0078-0502-61)
Price per Unit: $22.06757 per EA
Product Details
What is NDC 0078-0502?
What are the uses for Exelon?
What are Exelon Active Ingredients?
- RIVASTIGMINE 9.5 mg/24h - A carbamate-derived reversible CHOLINESTERASE INHIBITOR that is selective for the CENTRAL NERVOUS SYSTEM and is used for the treatment of DEMENTIA in ALZHEIMER DISEASE and PARKINSON DISEASE.
Which are Exelon UNII Codes?
The UNII codes for the active ingredients in this product are:
- RIVASTIGMINE (UNII: PKI06M3IW0)
- RIVASTIGMINE (UNII: PKI06M3IW0) (Active Moiety)
Which are Exelon Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- .ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1)
What is the NDC to RxNorm Crosswalk for Exelon?
- RxCUI: 1308569 - rivastigmine 13.3 MG/Day 24HR Transdermal System
- RxCUI: 1308569 - 24 HR rivastigmine 0.554 MG/HR Transdermal System
- RxCUI: 1308569 - rivastigmine 13.3 MG/Day 24HR Transdermal Patch
- RxCUI: 1308571 - EXELON PATCH 13.3 MG/Day 24HR Transdermal System
- RxCUI: 1308571 - 24 HR rivastigmine 0.554 MG/HR Transdermal System [Exelon]
Which are the Pharmacologic Classes for Exelon?
* Please review the disclaimer below.
Patient Education
Rivastigmine Transdermal Patch
Rivastigmine transdermal patches are used to treat dementia (a brain disorder that affects the ability to remember, think clearly, communicate, and perform daily activities and may cause changes in mood and personality) in people with Alzheimer's disease (a brain disease that slowly destroys the memory and the ability to think, learn, communicate and handle daily activities). Transdermal rivastigmine is also used to treat dementia in people with Parkinson's disease (a brain system disease with symptoms of slowing of movement, muscle weakness, shuffling walk, and loss of memory). Rivastigmine is in a class of medications called cholinesterase inhibitors. It improves mental function (such as memory and thinking) by increasing the amount of a certain natural substance in the brain.
[Learn More]
* Please review the disclaimer below.
[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
[2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
[4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".